Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
February's Most Popular Stories: Coronary IVL | Private equity & cardiology | ChatGPT | ICE & TEE | Much more
Thursday, March 2, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

The Month in Review

Editor's Note:

Almost all of our top stories this month look forward to cardiology’s future. New SCAI recommendations, for example, tell us that interventional procedures such as PCI and coronary IVL will start being performed more and more at outpatient cath labs throughout the country. Meanwhile, two key trends we highlighted this month—the rise of private equity investments and the evolution of AI—are expected to radically change the specialty in the years ahead.

As things continue to evolve, Cardiovascular Business will be there every step of the way. And we couldn’t do it without each and every one of you. Thank you for reading. – Michael Walter | Editor

Editor's Note:

Almost all of our top stories this month look forward to cardiology’s future. New SCAI recommendations, for example, tell us that interventional procedures such as PCI and coronary IVL will start being performed more and more at outpatient cath labs throughout the country. Meanwhile, two key trends we highlighted this month—the rise of private equity investments and the evolution of AI—are expected to radically change the specialty in the years ahead. As things continue to evolve, Cardiovascular Business will be there every step of the way. And we couldn’t do it without each and every one of you. Thank you for reading. – Michael Walter | Editor

Coronary IVL now recommended at all cath labs, even those without surgical backup

The latest SCAI guidance on the safety of PCI procedures included a key change that could expand coronary IVL utilization throughout the United States. 

READ MORE >
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.
Share on Twitter Share on Facebook Share on Linkedin

Coronary IVL now recommended at all cath labs, even those without surgical backup

Share on Twitter Share on Facebook Share on Linkedin
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.
The latest SCAI guidance on the safety of PCI procedures included a key change that could expand coronary IVL utilization throughout the United States. 
READ MORE >

Q&A: What the rise of private equity investments in cardiology means for cardiologists and their patients

Private equity investors have grown more and more interested in cardiology in recent years. Why the sudden shift? And what does it mean for patient care going forward? 

READ MORE >
Private equity investors have grown more and more interested in cardiology in recent years. Roger Strode, a partner with the global law firm Foley and Lardner LLP, explains why this is.
Share on Twitter Share on Facebook Share on Linkedin

Q&A: What the rise of private equity investments in cardiology means for cardiologists and their patients

Share on Twitter Share on Facebook Share on Linkedin
Private equity investors have grown more and more interested in cardiology in recent years. Roger Strode, a partner with the global law firm Foley and Lardner LLP, explains why this is.
Private equity investors have grown more and more interested in cardiology in recent years. Why the sudden shift? And what does it mean for patient care going forward? 
READ MORE >

Medtronic’s new extravascular ICD gains key approval

Unlike other ICDs, the lead for this new-look device is placed under the patient's breastbone, outside of their heart and veins. 

READ MORE >
Medtronic shared some good news with attendees at ESC Congress 2022 in Barcelona, the annual meeting of the European Society of Cardiology, noting that its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system met its safety endpoints in a global clinical trial. Medtronic EV ICD clinical trial safety endpoints ESC Congress 2022 #ESC #ESC2022 #ESC22
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s new extravascular ICD gains key approval

Share on Twitter Share on Facebook Share on Linkedin
Medtronic shared some good news with attendees at ESC Congress 2022 in Barcelona, the annual meeting of the European Society of Cardiology, noting that its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system met its safety endpoints in a global clinical trial. Medtronic EV ICD clinical trial safety endpoints ESC Congress 2022 #ESC #ESC2022 #ESC22
Unlike other ICDs, the lead for this new-look device is placed under the patient's breastbone, outside of their heart and veins. 
READ MORE >

FDA clears new AI-powered cardiac imaging solution

The newly approved software uses artificial intelligence to provide users with real-time feedback related to image quality.

READ MORE >
DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new AI-powered cardiac imaging solution

Share on Twitter Share on Facebook Share on Linkedin
DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images.
The newly approved software uses artificial intelligence to provide users with real-time feedback related to image quality.
READ MORE >

Cardiologists ask popular AI model ChatGPT to answer questions about cardiology

Can ChatGPT discuss preventive cardiology with patients? Cardiologists with Cleveland Clinic and Stanford University put the popular AI model to the test, sharing their findings in JAMA.

READ MORE >
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists ask popular AI model ChatGPT to answer questions about cardiology

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
Can ChatGPT discuss preventive cardiology with patients? Cardiologists with Cleveland Clinic and Stanford University put the popular AI model to the test, sharing their findings in JAMA.
READ MORE >

Can intracardiac echo replace TEE during structural heart procedures?

TEE has been used to guide most transcatheter structural heart cases over the past decade, but 3D ICE is changing how some centers image those patients. 

READ MORE >
A 3D intracardiac echo (ICE) view of a surgical mitral valve using the NuVision ultrasound catheter developed by Biosense Webster in partnership with GE Healthcare.
Share on Twitter Share on Facebook Share on Linkedin

Can intracardiac echo replace TEE during structural heart procedures?

Share on Twitter Share on Facebook Share on Linkedin
A 3D intracardiac echo (ICE) view of a surgical mitral valve using the NuVision ultrasound catheter developed by Biosense Webster in partnership with GE Healthcare.
TEE has been used to guide most transcatheter structural heart cases over the past decade, but 3D ICE is changing how some centers image those patients. 
READ MORE >

Abbott to acquire vascular disease specialists for $890M

Minnesota-based Cardiovascular Systems Inc. is perhaps best known for its atherectomy devices designed to treat PAD and CAD.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Abbott to acquire vascular disease specialists for $890M

Share on Twitter Share on Facebook Share on Linkedin
Minnesota-based Cardiovascular Systems Inc. is perhaps best known for its atherectomy devices designed to treat PAD and CAD.
READ MORE >

Confirmed: Long COVID more than doubles a person’s risk of heart issues

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 

READ MORE >
heart_body_blood_bloodvessel.jpg
Share on Twitter Share on Facebook Share on Linkedin

Confirmed: Long COVID more than doubles a person’s risk of heart issues

Share on Twitter Share on Facebook Share on Linkedin
heart_body_blood_bloodvessel.jpg
According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 
READ MORE >

New Jersey hospital performs 4,000th TAVR procedure

Morristown Medical Center first started performing TAVR procedures in 2011 and is now home to one of the largest TAVR programs in the United States. 

READ MORE >
Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.
Share on Twitter Share on Facebook Share on Linkedin

New Jersey hospital performs 4,000th TAVR procedure

Share on Twitter Share on Facebook Share on Linkedin
Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.
Morristown Medical Center first started performing TAVR procedures in 2011 and is now home to one of the largest TAVR programs in the United States. 
READ MORE >

Medtronic, Abbott share late-breaking TAVR data at CRT 2023

Both vendors used the four-day conference as an opportunity to provide key updates about their TAVR valves.

READ MORE >
Medtronic CoreValve Evolute
Share on Twitter Share on Facebook Share on Linkedin

Medtronic, Abbott share late-breaking TAVR data at CRT 2023

Share on Twitter Share on Facebook Share on Linkedin
Medtronic CoreValve Evolute
Both vendors used the four-day conference as an opportunity to provide key updates about their TAVR valves.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme